The Investment Blockchain of Record

Blockchain is over-hyped in many instances—but perhaps not this one

Jim Rundle

We’ve been comparatively restrained on blockchain. That’s not because we don’t think it’s important—clearly, dozens of banks can never be wrong about something, right? It’s because we feel that there’s a tendency to label blockchain as being all things to all people.

With Ibor, though, there could be a real use case brewing. Most solid movements within the blockchain world have focused primarily on two areas—asset transfer, be that currency, other materials, or information in underserved markets such as small-to-medium enterprise segments, or secondly, on the post-trade front.

But when I first started learning about blockchain—and I’ll admit to being late to the party on this, it was only when the financial services industry started sitting up and taking notice—one of the things that struck me was how similar the terminology was between Ibor and blockchain.

The basic description of an Ibor system is that it’s a platform designed to provide the front, middle and back offices of a financial institution with a single source of the truth. A blockchain system is designed as a distributed ledger where all nodes are in agreement over a single version of the truth.

It’s not too dissimilar, on a theoretical basis. There are major differences, of course. Ibor systems, particularly those currently in production by companies including SimCorp with its Dimension platform, or BlackRock with Aladdin—itself a descendant of one of the original Ibor systems that was built at Barclays Global Investors—are advanced technologies, feeding inputs from all areas of a business to create an interoperable database where all stakeholders can access particular views of information, confident that it is consistent across those views.

Then there are enhanced analytics layers, compatibility with multiple other systems, and its role as a nervous system for all areas of the business. It’s a pure data architecture project like few others.

Blockchain will take some development in order to be appropriate for this function, but an Ibor system built on blockchain architecture could, in theory, be a particularly powerful platform.

I’ll have a wider piece out on this next week, but feel free to shoot me your thoughts. I can be reached on james.rundle@incisivemedia.com.

This week on Buy-Side Technology:

  • Speaking of things that have far too much hype, my colleague Anthony Malakian takes a long look at artificial intelligence in this great piece, bringing in insights from Brown Brothers Harriman and others.
  • Euronext and LCH appear to have kissed and made up after the post-Deutsche Börse merger fallout, when let’s be honest, hardly anyone was at their best. Aside from me. I was on a Federally-mandated holiday at the time (not prison).
  • Fidelity announced its read-only update to its portfolio view, allowing Coinbase customers to view their bitcoin, ether and litecoin holdings as part of their overall assets, which we reported on last month, and again this week.
  • The Chicago Mercantile Exchange put the final nail in the coffin for its European clearinghouse, which further proves, along with the aforementioned London Stock Exchange-Deutsche Börse snafu, that Europe doesn’t much care for derivatives-market competition.
  • Finally, while we’re talking about derivatives, guess what might be in the European trading obligation’s future? That’s right, delays, if Isda et al get their way.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here